Navigation Links
Sanofi-aventis Announces 2007 Earnings Ahead of Guidance Sharp Rise in Proposed Dividend
Date:2/12/2008

MSD achieved 2007 full-year sales of euro 1,040 million, up 43.6% on a reported basis. Net sales of Gardasil(R) for the year totaled euro 341 million. Sanofi Pasteur MSD sales are not consolidated by sanofi-aventis.

(5) Internal estimate

Net sales by geographic region

Change on a Change on a

Q4 2007 comparable FY 2007 comparable

euro million net sales basis net sales basis

Europe 3,056 -0.4% 12,184 -0.4%

United States 2,181 -8.5% 9,474 +3.8%

Other Countries 1,674 +3.8% 6,394 +7.8%

TOTAL 6,911 -2.2% 28,052 +2.8%

Net sales fell slightly in Europe in the fourth quarter, mainly as a result of the continuing decline in net sales in Germany. Over 2007 as a whole, net sales were down by 0.4%, with the introduction of generics of Eloxatin(R) paring approximately 1.6% off growth for the period.

In the United States, fourth-quarter net sales were down 8.5%, affected by generics of Ambien(R) IR (which went off patent on April 20) and lower influenza vaccine sales (a substantial proportion of shipments having been postponed to the fourth quarter in 2006, making for a tough comparative). Excluding the effect of generics of Ambien(R) IR and of timing differences in shipments of vaccines, net sales growth in the United States would have been 14.4%. Over 2007 as a whole, net sales rose by 3.8%. After excluding the effect of generics of Ambien(R) IR from April 2007, net sales in the United States rose by 15.1%.

Fourth-quarter net sales in "Other Countries" increased by 3.8%, below the full-year growth rate. Excluding the effect of the repurchase of inventories from Astellas and Chugai following the signature of agreements with these two companies on
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine news :

1. Sanofi-Aventis renews licenses for Genomatix chip analysis pipeline
2. Sanofi-aventis US Chairman Tim Rothwell Addresses CMSAs Collaborative Practice Summit
3. Sanofi-aventis Announces a Good Third Quarter Performance; Increase in 2007 full-year earnings growth guidance
4. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
5. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
6. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
7. HEI, Inc. Announces Sale of RFID Division Assets
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
9. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
10. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
11. Brooke Franchise Corporation Announces Selected July Results

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2009)...earchers from the University of Michigan determine...on Americans with hepatitis C virus (HCV) infectio.... Treatment rates appear to be declining, in part...nfected. If this disturbing trend continues, by 2... will be prevented by antiviral therapy. This stu...
(Date:11/23/2009)...Taxpayers may be on the hook for the high cost of ...according to a new study led by a University of Br...study, published today in the Archives of Interna...pidogrel, a top-selling drug also known by the tra...eart attack or stroke. The drug was selected to st...
(Date:11/23/2009)...open on-the-job interaction might ease the problem...ealthDay News) -- Men who bottle up their anger ov... hearts, a new Swedish study indicates. , Men w... over conflicts with a fellow worker or supervisor...tack or die of heart disease as those who vented t...
(Date:11/23/2009)..., WASHINGTON,Nov.23/PRNewswire-USNewswire/--TheAm...balchildren,spublishing,education,andmediacompany,...encecurriculumdesignedtosparkinterestinthefieldsof...xcitingcareeropportunitiesinhematology. ,, "Man...hoolaboutHemotheMagnificent,whichmadelearningabout...
(Date:11/23/2009)...e everybody, health care professionals enjoy a pay... financial incentives for health care performance ...ws that patient-care performance ratings for 25 me...tly following the launch of a statewide pay-for-pe... focused on doctors, productivity. , Reportin...
Breaking Medicine News(10 mins):Health News:Alarming trend -- antiviral therapy to treat hepatitis C is declining in the US 2Health News:Drug ads ineffective for boosting sales, could cost taxpayers: UBC-Harvard study 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 2Health News:Stifled Anger at Work Doubles Men's Risk for Heart Attack 3Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 2Health News:New Science Program Teaches High School Students About Blood and Career Opportunities in the Field of Hematology 3Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 2Health News:Medical 'pay for performance' programs help improve care -- but not always, study finds 3
...e after major tissue damage or surgical interventi...ver resection is an established therapeutic measur...ance to know which molecular events underly the re...ent of Gastroenterology and Hepatology of the Univ...
...e professional antigen presenting cells (APCs) tha...DCs are cells in the pathway of antigen capture an... to directly prime nave CD4+ and CD8+ T cells. Gas...c cancer, as it has spread to the lymph glands and...
...rgeted therapies the highlights of 2008 , ...ainst cancer gathered steam in 2008, as new drugs ...d advances were made in both disease prevention an...es" across the gamut of cancer prevention, screeni...
...A record-setting 5,000 delegates and corporate lea...remier scientific conference on topics relating to...seases and disabilities associated with the biolog...ogies convened the world,s most innovative physici...
...At the 16th Annual World Congress on Anti-Aging Me...in Las Vegas, Zannos Grekos, MD, director of Cardi... ( www.regenocyte.com ), addressed physicians from...aftment of stem cells into damaged organs and subs...
...utation faced higher odds of heart attack, death, ... News) -- A gene variation can make younger heart ..., death or other heart problems if they receive th...n are often used to prevent blood vessels from clo...
Other Medicine News:Health News:Molecular events involved in liver regeneration 2Health News:A new light on tumor immunotherapy for gastric cancer 2Health News:Cancer Medicine Advances on Many Fronts 2Health News:Cancer Medicine Advances on Many Fronts 3Health News:Cancer Medicine Advances on Many Fronts 4Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 2Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 3Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 4Health News:5,000 Medical Leaders Report Latest Advancements in Biomedical Technologies; Breakthroughs by 2015 Predicted for Alzheimer's, Heart Disease, Cancer, and Diabetes 5Health News: Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference 2Health News: Stem Cells Poised to Grow Organs for Transplant : Zannos Grekos, MD Presents Clinical Data of Research with Adult Stem Cells to Physicians at International Regenerative Biomedicine Conference 3Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 2Health News:Gene Ups Risk for Those on Blood-Thinner Plavix 3
(Date:11/23/2009)...23/PRNewswire/--ProteonTherapeutics,Inc.,hasinitia...-201,inend-stagerenaldisease(ESRD)patientsundergoi...studyrepresentsProteon,ssecondhumanclinicalstudyin...tionofaPhase1/2studyofPRT-201inESRDpatientsundergo...ierthisyear.Proteonalsoannouncestheappointmentofbo...
(Date:11/23/2009)...Calif.,Nov.23/PRNewswire-FirstCall/--Anesiva,Inc.(...DavidC.U,PrichardhaveagreedtojointheAnesivaboardof...weenAnesivaandArcionTherapeutics.Completionoftheme...eatthepreviouslyannouncedAnesiva2009AnnualMeetingo...Tat400OysterPoint,Suite107A,SouthSanFrancisco,Cali...
(Date:11/23/2009)...23/PRNewswire-FirstCall/--RaptorPharmaceuticalCorp...uncedresultsfromaPhase2bclinicaltrialofitspropriet...ne")inpatientswithnephropathiccystinosis("cystinos...,SanDiego("UCSD")GeneralClinicalResearchCenter,eva...acodynamicsofasingledoseofDRCysteamineinninecystin...
Breaking Medicine Technology:Proteon Initiates Second Phase 1/2 Clinical Study of PRT-201 in Hemodialysis Patients 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 2Anesiva Announces Prospective Board Members To Be Appointed Upon Successful Completion of Proposed Merger 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 2Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 3Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 4Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis 5PracticeMatch Announces Departure From Physician Recruiting 53526 1PracticeMatch Announces Departure From Physician Recruiting 53526 2Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 53524 1Unilens Vision Inc Declares Regular Quarterly Cash Dividend of U S 240 09 Per Share 53524 2Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 1Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 2Perrigo Announces FDA Approval for Generic Version of NASACORT 28R 29 AQ 53522 3
...e start of TRILOGY ACS clinical trial to study ... ACS patients, TOKYO and INDIANAPOLIS, June 23 D... Lilly and Company (NYSE: LLY ),said that the U.S...the,review period for the prasugrel new drug appli...vided during the review period. This three,month e...
...fers Tips for Benefits/HR Managers, DALLAS, June ...departments can play an important role in preventi... heart attacks, according to a,leading prevention ...disease prevention., Dr. Boyd Lyles, corporate me...,s not uncommon for heart attacks to strike indivi...
Other Medicine Technology:FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 2FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 3FDA Extends Review Period for Daiichi Sankyo, Lilly Investigative Antiplatelet Drug, Prasugrel 4U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks 2U.S. Prevention Medicine: Employers Can Help Workers Avoid Heart Attacks 3
...thropoietin (EPO) is the primary known naturally-o...he predicted molecular weight of human EPO is 18.2... of EPO has an estimated molecular mass of ~30.5 k...tructure, the EPO receptor bears some homology to ...
...citonin is synthesized in the parafollicular C-cel...ry granules. The major action of calcitonin is to ... osteoclast activity, resulting in decreased mobil...ost evident in conditions associated with high lev...
...an chorionic gonadotropin (hCG) is a two chain (al...ted by the chorionic tissue of the placenta and is...y. Produced by the trophoblastic epithelium of the...in the early stages of pregnancy. The primary util...
2600KL ProPlus® Digital Wheelchair Ramp Scales
Medicine Products: